Mayo Launches Breast Cancer Sequencing, PGx Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mayo Clinic has launched a project that will use genome and tumor sequencing and mouse models to help develop and tailor breast cancer treatment and to discover why some tumors do not respond to therapy, Mayo said today.

Researchers in the Breast Cancer Genome Guided Therapy Study, or the Beauty Project, will sequence the genomes of breast cancer patients before they are treated and the genomes from their cancer tumors both before and after treatment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: CRISPR-based barcodes to trace cell lineages, and more.

The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.

French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.